Skip to main content
TipRanks
Go Ultimate75% OFF

Compare TG Therapeutics (NKB2) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:NKB2TG TherapeuticsCHF 8.30B87.22―Moderate BuyUnlock the CH:NKB2 analyst price target with TipRanks PremiumCH:NKB2Unlock the CH:NKB2 top-analyst price target with TipRanks Premium
PTGXProtagonist Therapeutics$134.38$8.80B26.0958.37%Strong BuyUnlock the PTGX analyst price target with TipRanks PremiumCH:NKB2 vs PTGXUnlock the PTGX top-analyst price target with TipRanks Premium
IMVTImmunovant$35.05$7.67B-13.8049.53%Moderate BuyUnlock the IMVT analyst price target with TipRanks PremiumCH:NKB2 vs IMVTUnlock the IMVT top-analyst price target with TipRanks Premium
ARQTArcutis Biotherapeutics$27.53$3.59B120.6717.40%Strong BuyUnlock the ARQT analyst price target with TipRanks PremiumCH:NKB2 vs ARQTUnlock the ARQT top-analyst price target with TipRanks Premium
LEGNLegend Biotech$18.54$3.79B-1861.95-40.53%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumCH:NKB2 vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$127.17$11.51B-35.23100.17%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumCH:NKB2 vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:NKB2TG Therapeutics―――
PTGXProtagonist Therapeutics134.3851.1461.44%
IMVTImmunovant35.0512.2353.59%
ARQTArcutis Biotherapeutics27.534.6720.43%
LEGNLegend Biotech18.54-12.47-40.21%
KYMRKymera Therapeutics127.1763.5499.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts